Clinical Trial Update: Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis

View source ↗

Summary

A clinical trial evaluating RCT-01 for unilateral chronic Achilles tendinosis has been withdrawn, ending long-term follow-up prospects for safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achilles Tendinopathy
• Achilles Tendinosis

Drugs mentioned

• RCT-01

Snippet

Sponsor: RepliCel Life Sciences, Inc. | Conditions: Tendinosis, Tendinopathy | Status: WITHDRAWN